Related references
Note: Only part of the references are listed.TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation
Tony J. Vanden Bush et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity
Ulrich Zaehringer et al.
IMMUNOBIOLOGY (2008)
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2008)
Overcoming immune tolerance against multiple myeloma with lentiviral calnexin-engineered dendritic cells
Shuhong Han et al.
MOLECULAR THERAPY (2008)
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
A. M. Krieg
ONCOGENE (2008)
B cell-intrinsic TLR signals amplify but are not required for humoral immunity
Almut Meyer-Bahlburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Arthur M. Krieg et al.
IMMUNOLOGICAL REVIEWS (2007)
Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses
Shen-Ying Zhang et al.
IMMUNOLOGICAL REVIEWS (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function
Wei Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105
Senad Divanovic et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
Jizhong Liu et al.
BLOOD (2007)
Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and toll-like receptors
Jin-Hwan Han et al.
IMMUNITY (2007)
TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses
Laurent Genestier et al.
JOURNAL OF IMMUNOLOGY (2007)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
Cutting edge:: Lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response
Joke M. M. den Haan et al.
JOURNAL OF IMMUNOLOGY (2007)
MyD88 is required for the formation of long-term humoral immunity to virus infection
Heath M. Guay et al.
JOURNAL OF IMMUNOLOGY (2007)
T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells
Yoshihiro Ueda et al.
JOURNAL OF IMMUNOLOGY (2007)
Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands
Isabelle Bekeredjian-Ding et al.
JOURNAL OF IMMUNOLOGY (2007)
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia
Ola Landgren et al.
BLOOD (2007)
Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents
Yonghong Shi et al.
CANCER RESEARCH (2007)
Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia
D. E. Spaner et al.
LEUKEMIA (2007)
The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease
P. G. Longo et al.
LEUKEMIA (2007)
Fc gamma RIIb controls bone marrow plasma cell persistence and apoptosis
Zou Xiang et al.
NATURE IMMUNOLOGY (2007)
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
Amanda L. Gavin et al.
SCIENCE (2006)
Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells
Siqing Wang et al.
BLOOD (2006)
Toll-like receptors in systemic autoimmune disease
Ann Marshak-Rothstein
NATURE REVIEWS IMMUNOLOGY (2006)
Heparanase, hyaluronan, and CD44 in cancers:: A breast carcinoma perspective
Martin Gotte et al.
CANCER RESEARCH (2006)
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
Devi K. Banerjee et al.
BLOOD (2006)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Toll-like receptor 2-mediated human B cell differentiation
Lisa M. Ganley-Leal et al.
CLINICAL IMMUNOLOGY (2006)
Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors
G Jego et al.
LEUKEMIA (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
TLR signaling
T Kawai et al.
CELL DEATH AND DIFFERENTIATION (2006)
HMGB1 expression and release by bone cells
K Charoonpatrapong et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Toll-like receptor stimulation as a third signal required for activation of human naive B cells
CR Ruprecht et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity
Jelena Tomic et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
M Ahmadzadeh et al.
BLOOD (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Immunomodulatory effects of toll-like receptor-7 activation on chronic lymphocytic leukemia cells
DE Spaner et al.
LEUKEMIA (2006)
Toll-like receptors mediate proliferation and survival of multiple myeloma cells
J Bohnhorst et al.
LEUKEMIA (2006)
Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses
C Dercamp et al.
CANCER RESEARCH (2005)
Toll-like, receptor 8-mediated reversal of CD4+ regulatory T cell function
GY Peng et al.
SCIENCE (2005)
Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the toll-like receptor-7/8 agonist, imiquimod
DE Spaner et al.
LEUKEMIA & LYMPHOMA (2005)
CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response
GSD Reid et al.
BLOOD (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Toll-like receptors, endogenous ligands, and systemic autoimmune disease
IR Rifkin et al.
IMMUNOLOGICAL REVIEWS (2005)
Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type IFN
IB Bekeredjian-Ding et al.
JOURNAL OF IMMUNOLOGY (2005)
Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response
M Odendahl et al.
BLOOD (2005)
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides
B Jahrsdorfer et al.
CLINICAL CANCER RESEARCH (2005)
CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10
B He et al.
JOURNAL OF IMMUNOLOGY (2004)
Endogenous ligands of toll-like receptors
MF Tsan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Tolerance, not immunity, crucially depends on IL-2
TR Malek et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Modulating vaccine responses with dendritic cells and Toll-like receptors
B Pulendran
IMMUNOLOGICAL REVIEWS (2004)
Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis
RD Sanderson et al.
MATRIX BIOLOGY (2004)
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells
E Bourke et al.
BLOOD (2003)
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
G Jego et al.
IMMUNITY (2003)
A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells
NL Bernasconi et al.
BLOOD (2003)
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
I Caramalho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Maintenance of serological memory by polyclonal activation of human memory B cells
NL Bernasconi et al.
SCIENCE (2002)
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
V Hornung et al.
JOURNAL OF IMMUNOLOGY (2002)
Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines
KA Zarember et al.
JOURNAL OF IMMUNOLOGY (2002)
Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II Fcγ receptor (CD32)
P Palmer et al.
VIROLOGY (2000)
Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: Costimulation with IL-2 results in a highly immunogenic phenotype
T Decker et al.
EXPERIMENTAL HEMATOLOGY (2000)
Share Paper
